Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

18

Portfolio Exits

11

About NMT Management AG - New Medical Technologies

NMT New Medical Technologies is a venture partner investing in medical and healthcare technologies and services. Its focus is to foster start-ups in Switzerland and the surrounding regions (Alpine Rim) as well as to invest globally in late stage private and promising public companies.NMT seeks investment opportunities in biopharmaceutical and medical technologies from universities and other private entities as well as spin-offs from large corporations. Furthermore, NMT attracts overseas start-ups, early- and late-stage companies to the Alpine Rim, supporting them in technology bundling and building up European operations as well as in going public.The Company was founded in 1997 by Roche, UBS and a small group of private investors. It was acquired by HbM BioVentures AG in February 2003.

NMT Management AG - New Medical Technologies Headquarter Location

Elisabethenstrasse 23

4051,

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NMT Management AG - New Medical Technologies Investments

18 Investments

NMT Management AG - New Medical Technologies has made 18 investments. Their latest investment was in Sunesis Pharmaceuticals as part of their PIPE - III on September 9, 2010.

CBI Logo

NMT Management AG - New Medical Technologies Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/9/2010

PIPE - III

Sunesis Pharmaceuticals

$15.5M

No

1/24/2003

Unattributed VC

Organ Recovery Systems

No

1/20/2003

Series B

Organ Recovery Systems

$14M

Yes

5/22/2002

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

9/7/2001

Series D

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/9/2010

1/24/2003

1/20/2003

5/22/2002

9/7/2001

Round

PIPE - III

Unattributed VC

Series B

Unattributed VC

Series D

Company

Sunesis Pharmaceuticals

Organ Recovery Systems

Organ Recovery Systems

Subscribe to see more

Subscribe to see more

Amount

$15.5M

$14M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

NMT Management AG - New Medical Technologies Portfolio Exits

11 Portfolio Exits

NMT Management AG - New Medical Technologies has 11 portfolio exits. Their latest portfolio exit was CardiacAssist on February 14, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/14/2018

Acquired

$99M

1

6/20/2013

IPO

$99M

1

9/27/2010

Acquired

$99M

2

5/5/2006

IPO

Subscribe to see more

$99M

Subscribe to see more

0

2/4/2005

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/14/2018

6/20/2013

9/27/2010

5/5/2006

2/4/2005

Exit

Acquired

IPO

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

1

2

0

0

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.